180 related articles for article (PubMed ID: 38443744)
1. Copper and Copper Complexes in Tumor Therapy.
Wang Y; Tang T; Yuan Y; Li N; Wang X; Guan J
ChemMedChem; 2024 Jun; 19(11):e202400060. PubMed ID: 38443744
[TBL] [Abstract][Full Text] [Related]
2. Copper homeostasis: Emerging target for cancer treatment.
Li Y
IUBMB Life; 2020 Sep; 72(9):1900-1908. PubMed ID: 32599675
[TBL] [Abstract][Full Text] [Related]
3. Novel metals and metal complexes as platforms for cancer therapy.
Frezza M; Hindo S; Chen D; Davenport A; Schmitt S; Tomco D; Dou QP
Curr Pharm Des; 2010 Jun; 16(16):1813-25. PubMed ID: 20337575
[TBL] [Abstract][Full Text] [Related]
4. Investigation of the cytotoxic implications of metal chelators against melanoma and approaches to improve the cytotoxicity profiles of metal coordinating agents.
Akladios FN; Andrew SD; Parkinson CJ
Biometals; 2016 Oct; 29(5):789-805. PubMed ID: 27389037
[TBL] [Abstract][Full Text] [Related]
5. Dendritic Pyridine-Imine Copper Complexes as Metallo-Drugs.
Laurent R; Maraval V; Bernardes-Génisson V; Caminade AM
Molecules; 2024 Apr; 29(8):. PubMed ID: 38675623
[TBL] [Abstract][Full Text] [Related]
6. An improved tumor-specific therapeutic strategy by the spatio-temporally controlled in situ formation of a Cu(ii) complex, leading to prompt cell apoptosis via photoactivation of a prodrug.
Chaudhuri A; Mengji R; Venkatesh Y; Jana A; Pradeep Singh ND
Chem Commun (Camb); 2020 Apr; 56(33):4559-4562. PubMed ID: 32202569
[TBL] [Abstract][Full Text] [Related]
7. Cu
Bykowska A; Komarnicka UK; Jeżowska-Bojczuk M; Kyzioł A
J Inorg Biochem; 2018 Apr; 181():1-10. PubMed ID: 29348049
[TBL] [Abstract][Full Text] [Related]
8. Novel copper complexes as potential proteasome inhibitors for cancer treatment (Review).
Zhang Z; Wang H; Yan M; Wang H; Zhang C
Mol Med Rep; 2017 Jan; 15(1):3-11. PubMed ID: 27959411
[TBL] [Abstract][Full Text] [Related]
9. Novel thiosemicarbazones of the ApT and DpT series and their copper complexes: identification of pronounced redox activity and characterization of their antitumor activity.
Jansson PJ; Sharpe PC; Bernhardt PV; Richardson DR
J Med Chem; 2010 Aug; 53(15):5759-69. PubMed ID: 20597487
[TBL] [Abstract][Full Text] [Related]
10. Copper(ii) complexes with tridentate halogen-substituted Schiff base ligands: synthesis, crystal structures and investigating the effect of halogenation, leaving groups and ligand flexibility on antiproliferative activities.
Kordestani N; Amiri Rudbari H; Fernandes AR; Raposo LR; Luz A; Baptista PV; Bruno G; Scopelliti R; Fateminia Z; Micale N; Tumanov N; Wouters J; Abbasi Kajani A; Bordbar AK
Dalton Trans; 2021 Mar; 50(11):3990-4007. PubMed ID: 33650599
[TBL] [Abstract][Full Text] [Related]
11. Metal Complexes or Chelators with ROS Regulation Capacity: Promising Candidates for Cancer Treatment.
Li X; Wang Y; Li M; Wang H; Dong X
Molecules; 2021 Dec; 27(1):. PubMed ID: 35011380
[TBL] [Abstract][Full Text] [Related]
12. Interaction of C20-substituted derivative of pregnenolone acetate with copper (II) leads to ROS generation, DNA cleavage and apoptosis in cervical cancer cells: Therapeutic potential of copper chelation for cancer treatment.
Zafar A; Singh S; Ahmad S; Khan S; Imran Siddiqi M; Naseem I
Bioorg Chem; 2019 Jun; 87():276-290. PubMed ID: 30908970
[TBL] [Abstract][Full Text] [Related]
13. Synthesis of novel coumarin nucleus-based DPA drug-like molecular entity: In vitro DNA/Cu(II) binding, DNA cleavage and pro-oxidant mechanism for anticancer action.
Khan S; Malla AM; Zafar A; Naseem I
PLoS One; 2017; 12(8):e0181783. PubMed ID: 28763458
[TBL] [Abstract][Full Text] [Related]
14. Modulation of Metal Homeostasis for Cancer Therapy.
Yang Y; Fan H; Guo Z
Chempluschem; 2024 Jun; 89(6):e202300624. PubMed ID: 38315756
[TBL] [Abstract][Full Text] [Related]
15. Copper(II)
Peña Q; Sciortino G; Maréchal JD; Bertaina S; Simaan AJ; Lorenzo J; Capdevila M; Bayón P; Iranzo O; Palacios Ò
Inorg Chem; 2021 Mar; 60(5):2939-2952. PubMed ID: 33596377
[TBL] [Abstract][Full Text] [Related]
16. Copper complexes of bis(thiosemicarbazones): from chemotherapeutics to diagnostic and therapeutic radiopharmaceuticals.
Paterson BM; Donnelly PS
Chem Soc Rev; 2011 May; 40(5):3005-18. PubMed ID: 21409228
[TBL] [Abstract][Full Text] [Related]
17. Targeting protein kinase and DNA molecules by diimine-phthalate complexes in antiproliferative activity.
Pravin N; Devaraji V; Raman N
Int J Biol Macromol; 2015 Aug; 79():837-55. PubMed ID: 26054665
[TBL] [Abstract][Full Text] [Related]
18. Salpyran: A Cu(II) Selective Chelator with Therapeutic Potential.
Devonport J; Bodnár N; McGown A; Bukar Maina M; Serpell LC; Kállay C; Spencer J; Kostakis GE
Inorg Chem; 2021 Oct; 60(20):15310-15320. PubMed ID: 34609139
[TBL] [Abstract][Full Text] [Related]
19. Antiproliferative and antibacterial properties of biocompatible copper(II) complexes bearing chelating N,N-heterocycle ligands and potential mechanisms of action.
Olar R; Badea M; Bacalum M; Răileanu M; Ruţă LL; Farcaşanu IC; Rostas AM; Vlaicu ID; Popa M; Chifiriuc MC
Biometals; 2021 Oct; 34(5):1155-1172. PubMed ID: 34350537
[TBL] [Abstract][Full Text] [Related]
20. Copper(II) Phenanthroline-Based Complexes as Potential AntiCancer Drugs: A Walkthrough on the Mechanisms of Action.
Masuri S; Vaňhara P; Cabiddu MG; Moráň L; Havel J; Cadoni E; Pivetta T
Molecules; 2021 Dec; 27(1):. PubMed ID: 35011273
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
